Imagen de Portada

Is There Any Association Between Periodontitis and Prostatic Alterations? A Systematic Review

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Beatriz Rodrigues Risuenho Peinado, Rayssa Maitê Farias Nazário, Deborah Ribeiro Frazão, Yago Gecy de Sousa Né, Leonardo Oliveira Bittencourt, Nathália Carolina Fernandes Fagundes, Caio Melo Mesquita, Cassiano Kuchenbecker Rösing, Renata Duarte de Souza‐Rodrigues, Luiz Renato Paranhos, Lucianne Cople Maia, Rafael Rodrigues Lima
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	The Prostate
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prostate and gut: Any relationship? A narrative review on the available evidence and putative mechanisms
por: Lorenzo Romano, et al.
Publicado: (2024)

Other‐cause mortality in incidental prostate cancer
por: Francesco Di Bello, et al.
Publicado: (2024)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
por: Takanori Tokunaga, et al.
Publicado: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
por: Yuto Ono, et al.
Publicado: (2025)

The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
por: Cevat İlteriş Kıkılı, et al.
Publicado: (2026)

Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
por: Hyun‐Kyung Ko, et al.
Publicado: (2025)

Cover Image: Volume 86 Issue 7
por: Amod Sharma, et al.
Publicado: (2026)

External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high‐grade prostate cancer patients
por: Nawar Touma, et al.
Publicado: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
por: Eric V. Li, et al.
Publicado: (2024)

Discovering the Prostate: Notes on History and Historiography
por: Diederik F. Janssen
Publicado: (2025)

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
por: Toshifumi Takahashi, et al.
Publicado: (2024)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
por: Fabian Falkenbach, et al.
Publicado: (2025)

Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and Agonists
por: Satı Coşkun Yazgan, et al.
Publicado: (2026)

Real‐World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Propensity‐Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis
por: Yosuke Yasuda, et al.
Publicado: (2026)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
por: Mark Kidd, et al.
Publicado: (2025)

Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience
por: Meryam Losee, et al.
Publicado: (2025)

Clinicopathological Significance of Extranodal Adipose Tissue Invasion in Metastatic Lymph Nodes in Patients With Prostate Cancer
por: Hirotaka Nagasaka, et al.
Publicado: (2024)

Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
por: Zhiyao Xu, et al.
Publicado: (2025)

Integration of Primary Care Into the Follow‐Up Protocol for Prostate Cancer Patients in Aragon, Spain. It Is Time to Follow Other Successful Models in the Region
por: Angel Borque‐Fernando, et al.
Publicado: (2025)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
por: Christian P. Pavlovich, et al.
Publicado: (2025)

Use of Droplet Digital PCR for Consistent Detection of TMPRSS2:ERG Gene Fusion Transcripts Initiated In Vitro
por: Megan H. Check, et al.
Publicado: (2025)

Challenging the Evolving Nomenclature of Ultrasound‐Guided Transperineal Prostate Biopsy: A Call for Standardization
por: Pedro Ivo C. Ravizzini, et al.
Publicado: (2026)

Real‐world prevalence of adverse events with first‐line systemic therapies among patients with metastatic castration‐sensitive prostate cancer
por: Umang Swami, et al.
Publicado: (2024)

Correction to “[Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study ( The Prostate , 2025). https://doi.org/10.1002/pros.70071]”
Publicado: (2026)

Robotic‐Assisted Radical Prostatectomy in the Elderly Patient—A Study of Functional, Surgical, and Oncological Outcomes in an Australian Cohort
por: Victor Yu, et al.
Publicado: (2025)

Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy
por: Shintaro Narita, et al.
Publicado: (2024)

Spatial Distribution of Prostate Cancer Missed by MRI‐Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort
por: Ruth Himmelsbach, et al.
Publicado: (2026)

Letter to the Editor Regarding “Challenging the Evolving Nomenclature of Ultrasound‐Guided Transperineal Prostate Biopsy: A Call for Standardization”
por: Eriz Özden, et al.
Publicado: (2026)

Ten‐year functional and oncological outcomes of a prospective randomized controlled trial comparing laparoscopic versus robot‐assisted radical prostatectomy
por: Enrico Checcucci, et al.
Publicado: (2024)

Issue Information
Publicado: (2024)

Overall and metastasis‐free survival of Afro‐Caribbean patients with biochemical recurrence after radical prostatectomy
por: Hugo Barriere, et al.
Publicado: (2024)

Comments on the Study “Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients”
por: Leibo Wang, et al.
Publicado: (2026)

A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer
por: Daniel Boiarsky, et al.
Publicado: (2024)

Impact of definitive radiotherapy on metabolic response measured with 68Ga‐PSMA‐PET/CT in patients with intermediate‐risk prostate cancer
por: Cem Onal, et al.
Publicado: (2024)

Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer
por: Julián Córdoba Sánchez, et al.
Publicado: (2024)

Issue Information
Publicado: (2026)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
por: Trevor C. Hunt, et al.
Publicado: (2025)

The 30th Annual Prostate Cancer Foundation Scientific Retreat Report
por: Andrea K. Miyahira, et al.
Publicado: (2024)

Issue Information
Publicado: (2025)

Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
por: Victor Sandoval, et al.
Publicado: (2025)